UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
UTAH MEDICAL PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
UTAH MEDICAL PRODUCTS INC revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global | $38.52M | $40.90M | $50.22M | $52.28M | $49.05M | $42.18M | $46.90M | $42.00M | $41.41M | $39.30M | 100.0% | -5.8% |
| OUS | $15.76M | $17.46M | $22.02M | $20.31M | $18.40M | $16.31M | $19.41M | $20.81M | $21.13M | $19.81M | 40.9% | -9.7% |
From the segment and revenue-disaggregation notes of Utah Medical Products's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.